Last reviewed · How we verify
NCT04337502
Clinical and Radiomic Model of COVID-19
trial testing Machine learning model in Coronavirus in 300 participants. Completed in 3 March 2020.
20 January 2020
Quick facts
| Lead sponsor | Maastricht University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 23 December 2019 |
| Primary completion | 20 January 2020 |
| Estimated completion | 3 March 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- Machine learning model
Conditions studied
- Coronavirus — all drugs for Coronavirus →
- Machine Learning — all drugs for Machine Learning →
Sponsor
Maastricht University
Who can join
Eligibility, any sex, with Coronavirus or Machine Learning. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To develop and validate a machine-learning model based on clinical, laboratory, and radiological characteristics alone or combination of COVID-19 patients to facilitate risk Assessment before and after symptoms and triage (home, hospitalization inward or ICU).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04337502
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Machine learning model
Trials testing the same drug.
- NCT06842446 — Systematic Machine Learning Algorithm for Rapid Thrombosis Detection · NA · recruiting
Other recruiting trials for Coronavirus
Currently open trials in the same condition.
- NCT04772170 — Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies · recruiting
- NCT05868239 — Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study · NA · recruiting
- NCT04359836 — A Study to Explore the Role of Gut Flora in COVID-19 Infection · recruiting
- NCT04376034 — Convalescent Plasma Collection and Treatment in Pediatrics and Adults · Phase 3 · recruiting
- NCT04568148 — COVID-19 Biorepository · active not recruiting
Other Maastricht University trials
Trials by the same sponsor.
- NCT07417059 — Sex Hormones Impact on Cannabis Response · NA · recruiting
- NCT07259005 — Breathe Hard to Breathe Easy: Online Breathwork-Assisted Therapy for Social Anxiety · NA · recruiting
- NCT06914648 — The Dragon PLC Trial (DRAGON-PLC) · NA · recruiting
- NCT07374926 — The Big Unknown: A Journey Into Generative AI's Transformative Effect on Medical Professions · NA · completed
- NCT06031818 — Usability and Clinical Effectiveness of an Interpretable Deep Learning Framework for Post-Hepatectomy Liver Failure Pred · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04337502 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Maastricht University
- Last refreshed: 7 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04337502.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing